Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06725810

Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease (CANNON)

A Prospective, Open-label, Randomized, Multicenter Study on the Rational Hemoglobin Target Value in Patients With Anemia of Non-dialysis Chronic Kidney Disease Treated With Enarodustat

Sponsor: Shanghai Zhongshan Hospital

Conditions Chronic Kidney Disease Associated Anemia

Interventions Enarodustat

Updated 2 times since 2025 Last updated: Jul 22, 2025 Started: Mar 27, 2025 Primary completion: Jan 1, 2029 Completion: Feb 1, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06725810, this PHASE4 trial focuses on Chronic Kidney Disease Associated Anemia and remains actively recruiting participants. Sponsored by Shanghai Zhongshan Hospital, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Aug 2025 — Present [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jan 2025 — Aug 2025 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Zhongshan Hospital

Data source: Shanghai Zhongshan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China